Nanobiotix, pioneer and leader in nanomedicine has developed a revolutionary concept dedicated to the local treatment of cancer. Nanobiotix is focused on the development of NanoXray, a pipeline of patented products, which are based on a physical mechanism of action: nanoparticles interact with X-rays and maximize the effect of radiotherapy within tumor cells. NanoXray products enhance the radiotherapy efficacy in the tumor without increasing healthy tissues damages.
Medical and Pharmaceutical Industries
Our unique gold nanoparticle labeling technology uses chemically cross-linked metal clusters and nanoparticles as labels.
Unlike conventional immunogold probes, in which colloidal gold particles are electrostatically adsorbed to antibodies and proteins, our gold nanoparticle labels are uncharged molecules which are cross-linked to specific sites on biomolecules. This gives our nanogold probes greater range and versatility than colloidal gold.
StoreDot is a company with a ground-breaking technology, based on its discovery of new generation, self-assembled Nanodots of biological origin. Representing elementary biological building blocks, these multifunctional Nanodots are at the core of several patented innovations by StoreDot, and constitute the future nanotechnology and advanced nano-photonic devices, including smartphones, TV’s, energy storage devices and more.
AMF-Nano Corporation is a young, innovative growth company that has developed patented wafer scale integration processes which will enable the design and manufacture of the next generation of large scale heterogeneous smart sensor systems in a robust, very reliable and cost-effective manner. The production methods the Company embraces utilize advanced microelectronic technologies to overcome and eliminate all the drawbacks found today in the traditional processes used for MEMs/CMOS integration.
The Utah Nanofab encompasses a class 100/1000/10,000 cleanroom, packaging, and test areas. Commissioned in 2012, the new 18,000 square foot facility provides the specialized custom-built infrastructure, equipment, processes, and expertise necessary for researchers and companies to design, build, and package revolutionary micro and nanoscale devices. Capabilities include device modeling, design layout, mask fabrication, thin film deposition, patterning, and device packaging.
The main business field of PlasmaChem concerns nano-materials, detonation-, vacuum-, plasma- and ultra-thin film technologies and their biomedical and technical applications.
The main technology points of PlasmaChem concern the development of processes induced by low-temperature plasma on different surfaces and in organized mono-molecular films (Langmuir-Blodgett and Self-Assembly Films), in atomically flat inorganic solids and in liquid interfaces and advanced technologies of synthesis and modification of nano-materials.
Optofluidics, Inc. is a venture backed life-sciences company that is developing microfluidic and biophotonic nanomanipulation technologies for biological, material science, and pharmaceutical applications. Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin NanoTechnology Institute. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
Ascent Bio-Nano Technologies, Inc. is a biotech start up based in State College, PA near Penn State University. We are located in the Technology Center Building, an incubator at Innovation Park.
Our Mission: to develop innovative biomedical instruments to accelerate the impact research makes to the society.
Current R&D Focus: Ascent is developing affordable, miniature flow cytometry devices for research applications. Our development is based on patented Biomedical Nano-Electro-Mechanical-Systems (BioNEMS) research results from Penn State University.